Global Legionella Testing Market

The Legionella Testing Market size was valued at USD 371.73 Million in 2025 and the total Legionella Testing Revenue is expected to grow at a CAGR of 8.7% from 2026 to 2032, reaching nearly USD 666.56 Million by 2032.

Legionella testing refers to a diagnostic method used for the detection of legionella that causes legionellosis. The disease is usually characterized as being similar to pneumonia, which requires extreme care and in some severe cases hospitalization of the patient. The prevalence of moisture in the air causes an increase in the prevalence of the bacteria.

To know about the Research Methodology :- Request Free Sample Report

1. The worldwide incidence of community-acquired pneumonia ranges from approximately 1.5 to 14 cases per 1000 people each year.

The rising prevalence of watery illnesses and rising public awareness of the dangers posed by Legionella bacteria have led to a notable increase in the worldwide market for Legionella testing. The prevalence of Legionnaires' disease, Pontiac fever, and pneumonia has been notably amplified by demographic trends, with the aging global population creating a higher susceptibility to these respiratory infections. The demand for Legionella testing has consequently soared, as healthcare systems, governments, and building owners recognize the need for proactive measures to safeguard public health. The market is highly competitive, with major players such as Quidel Corporation, Abbott Laboratories, and Bio-Rad Laboratories leading the global Legionella Testing Market. The global Legionella testing market is a critical component of public health strategies, driven by the increasing incidence of waterborne diseases and growing awareness of the risks associated with Legionella bacteria. The market is highly competitive, with major players leading the way in innovative testing solutions. Advancements in testing technologies, including point-of-care testing and digital platforms, are propelling the market's growth. The market is projected to witness significant growth in the coming years, driven by factors such as the increasing prevalence of Legionnaires' disease, the aging global population, and the growing demand for accurate and efficient diagnostic solutions.

Asia Pacific held a significant market share of about 20% in 2025 and is the fastest-growing region with an 8.7% CAGR in the Global Legionella Testing Market. Global players like Becton Dickinson and Thermo Fisher Scientific are entering the Asia Pacific market, increasing competition with established regional players like Neogen Corporation and HY Laboratories. The competition drives innovation and benefits the market with wider product availability. Urbanization and infrastructure development in China and India are increasing the risk of Legionella spread in complex water systems of new buildings, which drives market demand for regular testing to ensure occupant safety. Governments are promoting Legionella testing and water safety to raise public awareness, which creates a positive market environment. Increasing awareness of Legionnaires' disease and rising healthcare expenditure are driving the demand for preventive measures such as water management plans and regular Legionella testing, creating significant market opportunities.

Legionella Testing Market Dynamics

Rise in Waterborne Diseases and the Surge in Pneumonia

Waterborne diseases are on the rise, with pneumonia being a major concern. Legionnaires' disease, caused by Legionella bacteria is the leading cause of reportable outbreaks causing pneumonia and other respiratory illnesses. The increasing prevalence of Legionnaires' disease, Pontiac fever, and pneumonia, coupled with the growing elderly population, is driving the demand for Legionella testing. Aging water infrastructure in many regions creates conditions for harmful bacteria like Legionella to bloom. Climate change impacts water quality, leading to contamination and concentration of pollutants. Better detection and awareness of waterborne diseases are positive developments but require increased testing and preventative measures. With increased global travel and trade, waterborne pathogens easily cross borders, highlighting the need for stricter international standards and collaboration to control their spread. Governments, healthcare organizations, and building owners are implementing stricter regulations for testing to protect people's health. The market is offering faster and more accurate tests to meet the rising demand for Legionella testing. Point-of-care testing solutions and digital platforms streamline data management and improve efficiency in testing processes.

Advancements in Testing Technologies

Advancements in testing technologies are providing a significant opportunity for the Legionella Testing market, contributing to its promising potential and growth. These developments have led to more accurate and efficient testing procedures, thanks to progress in genomics and fast detection techniques. Innovative technologies like PCR, rapid antigen tests, LFIA, biosensors, and automation have revolutionized Legionella testing. These advancements offer faster results, ease of use, and real-time monitoring, empowering timely interventions and outbreak response. These testing solutions are becoming more affordable and user-friendly, opening up new potential for manufacturers who invest in research and development to bring innovative and advanced testing methods to the market. The ongoing development of testing apparatus and procedures is addressing the growing need for precise and affordable Legionella testing. Strategic alliances and collaborations between the water treatment sector and diagnostic labs are promoting a strong supply chain. These advancements not only cater to the demand for more sophisticated testing methods and technology but also contribute to the overall growth and evolution of the Legionella Testing market. Revolutionary advancements in testing technologies are providing a much-needed boost in the fight against Legionella, a potentially life-threatening bacteria present in water systems. These innovations are reshaping the Legionella Testing market, opening doors for more accurate, faster, and accessible detection methods, ultimately fostering a safer water environment

Legionella Testing Market Segment Analysis

Based on Test Type, the Microbial Culture segment held the largest market share of about XX% in the Global Legionella Testing Market in 2025. According to MMR analysis, the segment is further expected to grow at a CAGR of XX% during the forecast period and stands out as the dominant segment within the Global Legionella Testing Market. Culture media methods are widely used in laboratories to cultivate and isolate Legionella colonies, yielding accurate findings. Microbial culture offers high specificity and sensitivity, accurately identifying the presence of Legionella bacteria. Microbial culture provides valuable information for treating Legionnaires' disease by assessing antimicrobial susceptibility and helps manage infection risks by offering a comprehensive picture of bacterial characteristics. While microbial culture isolates and identifies particular species and serogroups, regulatory authorities require confirmatory testing using the method.

Microbial culture is a cost-effective option for testing compared to newer technologies like PCR. The initial setup cost may be higher for microbial culture, but the subsequent cost per test remains competitive. Additionally, Lab professionals have established workflows and expertise in microbial culture built over decades, transitioning to new technologies requires investment in training, equipment, and validation, which slows the adoption of alternatives. The market is highly competitive, with major competitors like Thermo Fisher Scientific, Merck KGaA, HiMedia Laboratories, and Neogen Corporation, investing in R&D to launch innovative technologies, broaden their product offerings, and obtain a competitive advantage.

Apart from that, Polymerase Chain Reaction (PCR) is the rapidly growing segment with a significant CAGR of XX% in the Legionella Testing Market. PCR provides results in hours, enabling faster outbreak control, risk mitigation, and patient management. It also boasts superior sensitivity in detecting small amounts of Legionella DNA. PCR technology has advanced, making it more user-friendly and accessible. Real-time PCR provides faster results with fewer manual steps. Multiplex PCR assays detect multiple Legionella species simultaneously, improving efficiency and providing valuable strain type information. PCR equipment costs are initially high but decrease per test thanks to technology and scale. Additionally, PCR is gaining acceptance as a microbial culture alternative by regulatory bodies boosting its confidence and adoption in the market.

Legionella Testing Market Regional Insights

North America dominated the Global Legionella Testing Market with the highest share of over XX% in 2025. The region is expected to grow at a CAGR of XX% during the forecast period and maintain its dominance. Strict laws and policies have been put in place in North America to prevent and control Legionella in several industries, including manufacturing, hospitality, and healthcare which has led to an increase in demand for testing services and solutions. The U.S. dominant in the North American Legionella Testing Market with a Market Share of about 30%, has regulatory bodies like the CDC (Centers for Disease Control and Prevention) and ASHRAE (American Society of Heating, Refrigerating, and Air Conditioning Engineers) that provide guidelines for Legionella management.

The region has a high rate of Legionnaire's disease diagnoses, a top-notch healthcare system, and greater public awareness of the illness, which fuels the local market. Technological developments in Legionella testing, including automated testing systems, quick diagnostic kits, and sophisticated molecular techniques, have also been observed in North America. Additionally, the presence of a large number of elderly populations that are vulnerable to the infection easily, coupled with stringent water testing regulations, prioritizes Legionella testing, boosting the regional market growth. The need for Legionella testing is further fueled by well-established industry practices in North America that place a high priority on water quality and safety.

Europe, a mature market in Legionella Testing held a market share of about 30% in 2025 and has strict regulations for monitoring and controlling Legionella, which drives demand for testing services and fuels market growth. Leading Key Players based in Europe, such as Becton Dickinson, BioMérieux, and Thermo Fisher Scientific offer different requirements and budgets. Europe is becoming more aware of the disease legionnaires', which is resulting in greater precautions and Legionella testing as part of risk management methods. The trend is noticeable in nations with high reported case counts, such as France, Germany, Italy, and Spain. Water quality is a top priority in Europe, and aging water infrastructure in many countries creates opportunities for Legionella testing services as the bacteria's tendency to spread in older systems requires regular testing for public safety. Europe has strict regulations for monitoring and controlling Legionella, which drives demand for testing services and fuels market growth.

Legionella Testing Market Competitive Landscapes

The market for Legionella Testing is competitive with key players including Abbott (Alere), Merck KGaA, IDEXX Corporation, Thermo Fisher Scientific Inc., Bio-Rad Laboratories, Inc., Pall Corporation, and Becton, Dickinson, and Company. The strict water treatment regulations, increasing population and urbanization, and the increased need for new water resources make the market competitive. The key players are adopting collaborative strategies like mergers and acquisitions, product launches, and joint ventures to expand the consumer base in the market. The market for Legionella Testing is competitive and dynamic, thanks to rising awareness, adoption of new techniques, growing healthcare infrastructure, and rising medical tourism.

1. Eurofins Scientific acquired Bio-Rad Clinical Diagnostics in February 2023 consolidating Eurofins' position as a global leader in Legionella testing, broadening their service portfolio and geographic reach.

2. Mérieux NutriSciences acquired Silliker Laboratories in January 2023 and strengthened Mérieux's environmental testing capabilities, including Legionella analysis, catering to diverse industries.

3. Bio-Rad Laboratories partnered with Quidel Corporation to expand access to Quidel's point-of-care Legionella antigen test, leveraging Bio-Rad's distribution network to reach more healthcare settings in 2023.

4. In 2023, Hygiena partnered with RKI-CERT GmbH and focuses on standardizing and validating Legionella testing methods, promoting accuracy and reliability across the industry.

Legionella Testing Market Scope: Inquire before buying

Legionella Testing Market, by Region

North America (United States, Canada, and Mexico)
Europe (UK, France, Germany, Italy, Spain, Sweden, Austria, and the Rest of Europe)
Asia Pacific (China, South Korea, Japan, India, Australia, Indonesia, Malaysia, Vietnam, Taiwan, Bangladesh, Pakistan, and the Rest of APAC)
Middle East and Africa (South Africa, GCC, Egypt, Nigeria, and the Rest of ME&A)
South America (Brazil, Argentina Rest of South America)

Legionella Testing Market, Key Players

1. Quidel Corporation
2. Abbott (Alere)
3. Merck KGaA
4. IDEXX Corporation
5. Thermo Fisher Scientific Inc.
6. Bio-Rad Laboratories, Inc.
7. Pall Corporation
8. Becton, Dickinson, and Company
9. Albagaia Ltd
10. Pro-lab Diagnostics, Inc.
11. Beckman Coulter, Inc.
12. Alere Inc.
13. Roche Diagnostics
14. Eiken Chemical Co. Ltd.,
15. Hologic, Inc.
16. QIAGEN, Takara Bio, Inc.
17. Environmental Safety Technologies, Inc.
18. LuminUltra Technologies Ltd.
19. BioAlert Solutions
20. Pacific Water Technology
21. Aquacert Ltd.
22. DTK Water
23. Sens Solutions
24. Genomadix, Inc.
25. Phigenics, LLC